KORU Medical names Adam Kalbermatten as chief commercial officer
Go back to KORU Medical names Adam Kalbermatten as chief commercial officer| (NASDAQ: KRMD) | Delayed: 3.16 +0.01 (0.32%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.15 | 52 Week High | $ | |||
| Open | $3.18 | 52 Week Low | $ | |||
| Day High | $3.19 | P/E | N/A | |||
| Day Low | $3.14 | EPS | $ | |||
| Volume | 129,469 | |||||

